| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | CA125 |
| Clinical data | |
| Trade names | OvaRex |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Molar mass | ca. 150 kg/mol |
 
(what is this?)
(verify) | |
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer. [1]
This drug was developed by AltaRex Corp.
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | CA125 |
| Clinical data | |
| Trade names | OvaRex |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Molar mass | ca. 150 kg/mol |
|
(what is this?)
(verify) | |
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer. [1]
This drug was developed by AltaRex Corp.
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.
|
| This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
|
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |